Consistently, miR-133a results to be less expressed in colon cancer tissue rather than in the normal tissues (Figure 9F), thus demonstrating the connection between the loss of miR-133a during tumour development, with the TPM4 upregulation. Here, TPM4 is linked to malignant colon neoplasm.